Previous close | 95.63 |
Open | 95.10 |
Bid | 98.10 x 1000 |
Ask | 98.93 x 900 |
Day's range | 94.94 - 99.09 |
52-week range | 91.66 - 114.36 |
Volume | |
Avg. volume | 423,914 |
Market cap | 5.338B |
Beta (5Y monthly) | 0.99 |
PE ratio (TTM) | 43.17 |
EPS (TTM) | 2.28 |
Earnings date | 24 Apr 2023 - 28 Apr 2023 |
Forward dividend & yield | 1.34 (1.28%) |
Ex-dividend date | 28 Feb 2023 |
1y target est | 126.91 |
Ashland (ASH) benefits from healthy demand in most consumer end markets, the Schulke & Mayr acquisition and its pricing and mix improvement actions to counter inflation.
Key Insights Ashland's estimated fair value is US$147 based on 2 Stage Free Cash Flow to Equity Ashland is estimated to...
Ashland (ASH) benefits from strength in its global pharma business, the Schulke & Mayr acquisition and its pricing and mix improvement actions to counter inflation.